Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
Cleaved-MMP-27 (Y99) Peptide BS7061P
Product NameCleaved-MMP-27 (Y99) Peptide
Catalog No.BS7061P
ApplicationsBlocking
Swiss-ProtQ9H306
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide Cleaved-MMP-27 (Y99). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS7061 Cleaved-MMP-27 (Y99) pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
Cleaved-MMP-27 (Y99) Peptide
Applications :
Blocking
Background :
Metalloproteinases (MMPs) are a family of proteins that are involved in the breakdown of the extracellular matrix during normal cellular events, including reproduction, tissue remodeling and embryonic development. MMPs are crucial in tumor invasion and building of metastatic formations because of their ability to degrade extracellular matrix proteins such as fibronectin, laminin, gelatins and/or collagen. MMP-27 (matrix metallopeptidase 27) is a 513 amino acid secreted protein that is expressed in B-cells. Belonging to the peptidase M10A family, MMP-27 contains four hemopexin-like domains, which is suggested to be involved in substrate recognition. MMP-27, along with other MMP family members, is associated with breast cancer development and tumor progression.
Alternative Name :
Matrix metalloproteinase-27; MMP-27; MMP27; UNQ2503/PRO5992
Swiss-Prot :
Q9H306
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide Cleaved-MMP-27 (Y99). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS7061 Cleaved-MMP-27 (Y99) pAb.
Blocking peptide available as BS7061PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER